Fischer Medical Ventures Stock Screener | Share Price & Fundamental Analysis

FISCHER Commodity Chemicals
Share Price NSE
₹40.13
▼ -0.71 (-1.74%)
2026-04-13 00:00:00
Share Price BSE
₹40.18
▼ -0.61 (-1.50%)
2026-04-13 00:00:00
As of April 13, 2026, the Fischer Medical Ventures share price (NSE: FISCHER) is ₹40.13 on NSE and ₹40.18 on BSE, down 1.74% from the previous close, with shares trading between ₹39.28 and ₹41.29, and a 52-week range of ₹33.20–₹1,156.20. Browse FISCHER balance sheet details to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Fischer Medical Ventures Market Cap ₹2,648.54 Cr.
FISCHER P/E Ratio (TTM) 68.45
Fischer Medical Ventures P/B Ratio 7.19
EPS (TTM) ₹0.08
Dividend Yield 0.01%
Debt to Equity 0.21
FISCHER 52 Week High ₹1156.20
Fischer Medical Ventures 52 Week Low ₹33.20
Operating Margin 5.00%
Profit Margin 2.04%
FISCHER Revenue (TTM) ₹49.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹457.00
Total Equity ₹338.00

Fischer Medical Ventures Share Price History - Stock Screener Chart

Screen FISCHER historical share price movements with interactive charts. Analyze price trends and patterns.

Fischer Medical Ventures Company Profile - Fundamental Screener

Screen Fischer Medical Ventures company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FISCHER shares.
Sector Chemicals
Industry Commodity Chemicals
Sub-Sector Commodity Chemicals
Segment E
ISIN INE771F01041

Fischer Medical Ventures Balance Sheet Screener

Screen FISCHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023
Assets
Total Assets 457 86 0
Current Assets 365 70 0
Fixed Assets 24 15 0
Liabilities
Total Liabilities 0 0 0
Current Liabilities 18 1 1
Non-Current Liabilities 0 0 0
Shareholders' Equity
Total Equity 338 81 0
Share Capital 64 54 0
Reserves & Surplus 244 27 0

Fischer Medical Ventures Income Statement Screener - Profit & Revenue Analysis

Screen Fischer Medical Ventures income statement and profit fundamentals. Analyze FISCHER quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Fischer Medical Ventures share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Jun 2023-Sept 2023-Dec
Revenue 49 31 89 102 21 11 40 12 0 0 0
Expenses 47 19 70 80 18 10 39 11 0 0 1
EBITDA 3 12 19 23 3 1 1 1 0 0 -1
Operating Profit % 5.00% 18.00% 19.00% 21.00% 12.00% -3.00% 1.00% 3.00% 0.00% 0.00% -347.00%
Depreciation 1 1 1 1 0 0 0 1 0 0 0
Interest 0 1 1 1 0 0 0 0 0 0 0
Profit Before Tax 2 10 17 21 3 0 0 0 0 0 -1
Tax 1 5 3 2 0 0 0 0 0 0 0
Net Profit 1 5 14 19 3 0 0 0 0 0 -1
EPS -0.05 0.77 0.22 0.30 0.48 0.65 0.05 -0.05 0.00 0.00 0.00

Fischer Medical Ventures Cash Flow Screener - Liquidity Fundamentals

Screen FISCHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March
Operating Activities -87 -7
Investing Activities -125 -29
Financing Activities 315 37
Net Cash Flow 103 1

Fischer Medical Ventures Shareholding Pattern Screener

See Fischer Medical Ventures shareholding pattern with promoter, FII, and DII holdings. Check Fischer Medical Ventures promoter holding and ownership changes for FISCHER on TickJournal.
Item 2025-Feb 2025-Mar 2025-Apr 2025-Jun 2025-Jul 2025-Sept 2025-Dec 2024-Jan
Promoter Holding 62.81% 62.81% 61.80% 61.80% 61.80% 61.80% 61.80% 0.00%
FII Holding 5.06% 5.23% 5.38% 5.55% 0.00% 5.61% 4.85% 0.00%
DII Holding 1.41% 1.44% 1.42% 1.42% 0.00% 1.42% 1.36% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 25.30% 26.52% 27.48% 26.48% 26.47% 26.23% 26.14% 29.75%
Other Holding 5.41% 3.99% 3.93% 4.75% 11.74% 4.95% 5.85% 70.25%
Shareholder Count 9,865 10,180 10,182 10,058 10,050 12,127 22,920 9,065

Fischer Medical Ventures Share Dividend Screener - Share Yield Analysis

Check Fischer Medical Ventures dividend history with payout and yield data. View Fischer Medical Ventures dividend details including ex-dates and amounts for FISCHER stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.05 0.12%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Fischer Medical Ventures Stock Index Membership

See which indices include Fischer Medical Ventures stock. Check FISCHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Fischer Medical Ventures is not part of any tracked indices.
Only major market indices are tracked in our system.

Fischer Medical Ventures Market Events Screener - Corporate Actions

Get Fischer Medical Ventures corporate actions including splits, bonuses, and buybacks. Check Fischer Medical Ventures stock events that may affect FISCHER share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -2.43%
Annual General Meeting NA 18.86%
Dividend ₹ 0.00 /share 33.62%
2025-07-28 Split 1:10 0.00%
2026-01-30 2026-01-30 Quarterly Result Announcement NA 1.07%
2025-10-28 2025-10-28 Quarterly Result Announcement NA 11.81%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.86%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 2.45%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 1.26%
2025-01-31 2025-01-31 Extraordinary General Meeting NA 0.40%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 2.38%
2024-03-29 2024-03-29 Change Of Name NA 0.00%
2024-01-13 2024-01-13 Extraordinary General Meeting NA 35.66%
2023-04-28 2023-04-28 Extraordinary General Meeting NA 11.76%

Fischer Medical Ventures Competitors Screener - Peer Comparison

Screen FISCHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Tata Chemicals 17,576 46.99 15,112 -3.79% 354 58.53
Deepak Fertilisers & Petrochemicals 13,745 15.22 10,355 17.69% 945 63.06
Gujarat Narmada Valley Fert & Chem 6,355 10.11 8,393 -0.07% 586 55.97
Gujarat Alkalies & Chemicals 4,539 -527.56 4,165 6.89% -65 67.61
TANFAC Industries 4,472 57.71 560 45.35% 88 65.43
GHCL 4,369 8.46 3,271 -6.51% 624 55.88
Chemplast Sanmar 3,856 -13.28 4,393 9.61% -110 42.18
Fischer Medical Ventures 2,649 68.45 112 421.86% 1 59.66
Thirumalai Chemicals 2,269 -14.40 2,070 -1.54% -46 55.66
Grauer & Weil 1,659 20.67 1,180 7.28% 157 58.46

Fischer Medical Ventures Company Announcements - News Screener

Screen FISCHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-04 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-31 Announcement under Regulation 30 (LODR)-Allotment -
2026-03-30 Closure of Trading Window -
2026-03-24 Board Meeting Outcome for Appointment Of Company Secretary And Compliance Officer -
2026-03-20 Closure of Trading Window -
2026-03-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-03 Announcement Under Reg 30 -
2026-02-12 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-02-09 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-02-06 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-02-06 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-01-30 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-01-30 Announcement Under Reg-30 -
2026-01-30 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-01-30 Results- Financial Results-31/12/2025 -
2026-01-30 Board Meeting Outcome for Outcome Of The Board Meeting Held On 30/01/2026 -
2026-01-23 Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31 2025 And To Transact Any Other Matter As May Be Specified In The Agenda. -
2026-01-21 General Update -
2026-01-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -